Working together for a sustainable future: Bürkert Fluid Control Systems and Green Elephant Biotech
February 13, 2025
Family business invests in start-up Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor, so the two companies can work together to develop more efficient, flexible, and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more cost-effective production of therapeutics and facilitate [...]
February 12, 2025
TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of autoimmune diseases ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, [...]
February 12, 2025
The Invitrogen™ EVOS™ S1000 Spatial Imaging System features intuitive software that empowers researchers to achieve more with their tissue samples while reducing sample processing time. WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses the limitations of current [...]
February 12, 2025
ALTRACE Energy Dispersive X-Ray Fluorescence Spectrometer Shimadzu Corporation has released the ALTRACE energy dispersive X-ray fluorescence spectrometer. The ALTRACE is the flagship model of Shimadzu energy dispersive X-ray fluorescence spectrometers (EDX). Its X-ray optical system and signal processing system have been completely redesigned, and it provides high-sensitivity measurements of trace inorganic elements. Up to 48 samples [...]
February 12, 2025
UV-1900i Plus UV-2600i/2700i Plus Shimadzu Corporation has released 3 models of UV-VIS spectrophotometers globally. The UV-1900i Plus, UV-2600i Plus, and UV-2700i Plus, the successor models to the UV-i Selection, provide wide-ranging support for the needs of users. This includes high-level operability through a variety of user support functions, as well as a wealth of functions for accommodating [...]
Phase Holographic Imaging Announces Management Changes
February 11, 2025
Recent technical progress has led the Board of Directors of Phase Holographic Imaging (PHI) to decide to focus resources on the company’s clinical product development program. In relation to this, the Board of Directors has, in discussion with CEO Anders Månsson, decided to initiate the search for a new CEO to lead the ambitious development [...]
IDBS earns Bronze Medal from EcoVadis for sustainability performance
February 11, 2025
Woking, UK — IDBS, a leading provider of cloud software for BioPharma companies, announced today that it has achieved a Bronze Medal from EcoVadis, a global leader in business sustainability assessments. IDBS scored a 65, placing the company in the top 80th percentile globally. The EcoVadis assessment evaluates 21 sustainability criteria across four core themes: Environment, Labor & Human [...]
Stellaromics Secures Significant Funding to Advance 3D Spatial Biology
February 11, 2025
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON -- Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), today announced the completion of a Series B funding round in the amount of $80M. [...]
February 10, 2025
Seattle, WA – Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) U.S. Patent No. 12,178,835. This patent marks a significant milestone in Pluristyx's mission to bring advanced cell therapy solutions to the global market. Additionally, patents for iACT Stealth™ have been issued or are [...]
February 10, 2025
Tokyo, Japan and Toronto, Canada -- PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturing of cell and gene therapy (CGT) products. This joint initiative will integrate “LiCellGrow™(*2), PHC’s cell expansion system under development, with CCRM’s [...]

